Private Portfolio Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Private Portfolio Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,138	Closed	-$202K	–	264
2021 Q2	$202K	Buy	+1,138	New	+$197K	0.06%	255
2019 Q3	–	Sell	-1,442	Closed	-$206K	–	213
2019 Q2	$206K	Sell	1,442 -26	-2%	-$3.49K	0.09%	211
2019 Q1	$210K	Buy	+1,468	New	+$191K	0.11%	185

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Private Portfolio Partners's JAZZ Position: Q3 2021 in Review

Private Portfolio Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 1,138 shares — an estimated $202K sold.

Private Portfolio Partners first reported a position in JAZZ in Q1 2019 and held it in 3 quarters. The position peaked at $210K in Q1 2019. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

Private Portfolio Partners reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Private Portfolio Partners sold 1,138 Jazz Pharmaceuticals shares in Q3 2021, an estimated $202K.
Private Portfolio Partners first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 3 quarters.
Private Portfolio Partners's Jazz Pharmaceuticals position peaked at $210K in Q1 2019.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Private Portfolio Partners's 13F filing for Q3 2021, filed 4 Nov 2021.